ELRIG CRISPR in Drug Discovery 2019: From Targets to Therapeutics
This meeting will focus on the application of genome engineering to identify novel drug targets through large scale CRISPR based functional genomics studies, target validation in developing advanced cellular and in vivo disease models, and the pioneering applications in therapeutic genome editing.